Enhancing Immunogenicity of Cancer Vaccines: QS-21 as an Immune Adjuvant
Journal:
Current Drug Therapy
Volume:
6
Page:
207-212
Author(s):
David Y. Gin and Susan F. Slovin
Malignant Hypercalcemia
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
3462-3467
Author(s):
U. Basso, M. Maruzzo, A. Roma, V. Camozzi, G. Luisetto and F. Lumachi
From the Sea to Anticancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
3551-3562
Author(s):
P. Russo, C. Nastrucci and A. Cesario
Multifaceted Role of Neuropilins in Cancer
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
3563-3575
Author(s):
S. Rizzolio and L. Tamagnone
New Perspectives in Glioma Immunotherapy
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
2439-2467
Author(s):
Antonio Daga, Cristina Bottino, Roberta Castriconi, Rosaria Gangemi and Silvano Ferrini
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
144-150
Author(s):
Michel Choueiri, Nizar Tannir and Eric Jonasch
Immunotherapy of Kidney Cancer
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
151-163
Author(s):
Petros D. Grivas and Bruce G. Redman
VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
164-168
Author(s):
Toni K. Choueiri
Therapy for Non-Clear Cell Histologies in Renal Cancer
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
169-180
Author(s):
Rhonda L. Bitting, John Madden and Andrew J. Armstrong
Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma
Journal:
Current Clinical Pharmacology
Volume:
6
Page:
181-188
Author(s):
Priti Patel and Sandy Srinivas